Detalhe da pesquisa
1.
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.
Hepatology
; 77(4): 1228-1240, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993369
2.
The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.
Int J Mol Sci
; 25(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338821
3.
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Gut
; 72(8): 1581-1591, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788015
4.
Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.
Gut
; 71(2): 402-414, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479052
5.
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
Gut
; 70(2): 379-387, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241903
6.
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
J Hepatol
; 74(5): 1097-1108, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227350
7.
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.
J Hepatol
; 73(5): 1082-1091, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32339602
8.
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
J Hepatol
; 73(4): 842-854, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673741
9.
Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats.
Int J Mol Sci
; 21(9)2020 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392802
10.
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview.
Int J Mol Sci
; 21(6)2020 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188134
11.
Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis.
Am J Physiol Gastrointest Liver Physiol
; 317(2): G182-G194, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188634
12.
ß-Arrestin2 is increased in liver fibrosis in humans and rodents.
Proc Natl Acad Sci U S A
; 117(44): 27082-27084, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33144522
13.
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
Gut
; 66(1): 145-155, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385087
14.
Rationale for the use of statins in liver disease.
Am J Physiol Gastrointest Liver Physiol
; 312(5): G407-G412, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280144
15.
Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1ß in liver cirrhosis.
Gut
; 70(9): 1799-1800, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087491
16.
Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS.
Gut
; 69(8): 1535-1536, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270166
17.
Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?
J Hepatol
; 73(4): 980-982, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698966
18.
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.
Liver Transpl
; 26(12): 1652-1657, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885580
19.
Circulating microbiome in blood of different circulatory compartments.
Gut
; 68(3): 578-580, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581241
20.
Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot study.
Intern Emerg Med
; 19(3): 713-720, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38409619